Explore more publications!
STEM Times of Connecticut
Got News to Share?

STEM Times of Connecticut: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Times of Connecticut.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 10, 2025

Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease
December 10, 2025

Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease

Indeterminate GlobeNewswire
Genius Group Executes Fourth Buyback of One Million Shares
December 10, 2025

Genius Group Executes Fourth Buyback of One Million Shares

Indeterminate GlobeNewswire
Fulcrum Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering of Common Stock and Pre-Funded Warrants
December 10, 2025

Fulcrum Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire
BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025
December 10, 2025

BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025

Indeterminate GlobeNewswire
ProMIS Neurosciences Announces New Peer-Reviewed Publication Highlighting Selective Targeting of Toxic Oligomers for Potential Clinical Benefit and Reduced ARIA Risk
December 10, 2025

ProMIS Neurosciences Announces New Peer-Reviewed Publication Highlighting Selective Targeting of Toxic Oligomers for Potential Clinical Benefit and Reduced ARIA Risk

Indeterminate GlobeNewswire
Kane Biotech Receives Health Canada Approval for revyve® Antimicrobial Wound Gel Spray
December 10, 2025

Kane Biotech Receives Health Canada Approval for revyve® Antimicrobial Wound Gel Spray

Indeterminate GlobeNewswire
sensiBel Eval Kits Accelerate Applications of World’s First Studio-quality Optical MEMS Microphone
December 10, 2025

sensiBel Eval Kits Accelerate Applications of World’s First Studio-quality Optical MEMS Microphone

Indeterminate GlobeNewswire
Sagimet’s License Partner Ascletis Announced Acceptance of New Drug Application for Denifanstat for the Treatment of Moderate to Severe Acne by China’s National Medical Products Administration
December 10, 2025

Sagimet’s License Partner Ascletis Announced Acceptance of New Drug Application for Denifanstat for the Treatment of Moderate to Severe Acne by China’s National Medical Products Administration

Indeterminate GlobeNewswire
Yodeck Redefines Intelligent Digital Signage Through Innovation, Partnerships, and People
December 10, 2025

Yodeck Redefines Intelligent Digital Signage Through Innovation, Partnerships, and People

Indeterminate GlobeNewswire
Aeluma CEO and CFO to Participate in Fireside Chat with Benchmark Company Semiconductor Analyst David Williams on December 18
December 10, 2025

Aeluma CEO and CFO to Participate in Fireside Chat with Benchmark Company Semiconductor Analyst David Williams on December 18

Indeterminate GlobeNewswire
Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration
December 10, 2025

Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration

Indeterminate GlobeNewswire
Aurora Mobile’s EngageLab Introduces Advanced Behavioral CAPTCHA to Strengthen Digital Security and User Experience
December 10, 2025

Aurora Mobile’s EngageLab Introduces Advanced Behavioral CAPTCHA to Strengthen Digital Security and User Experience

Indeterminate GlobeNewswire
Mimecast Expands APAC Investment to Accelerate Human Risk Management Growth
December 10, 2025

Mimecast Expands APAC Investment to Accelerate Human Risk Management Growth

Indeterminate GlobeNewswire
JASCAYD® (nerandomilast) receives first regulatory approval for progressive pulmonary fibrosis in China
December 10, 2025

JASCAYD® (nerandomilast) receives first regulatory approval for progressive pulmonary fibrosis in China

Indeterminate GlobeNewswire
EngageLab Introduces Advanced Behavioral CAPTCHA to Strengthen Digital Security and User Experience
December 10, 2025

EngageLab Introduces Advanced Behavioral CAPTCHA to Strengthen Digital Security and User Experience

Indeterminate GlobeNewswire
Igyxos Biotherapeutics Announces Positive Results from Phase 1 Trial of IGX12, its First-in-Class Monoclonal Antibody for the Treatment of Male and Female Infertility
December 10, 2025

Igyxos Biotherapeutics Announces Positive Results from Phase 1 Trial of IGX12, its First-in-Class Monoclonal Antibody for the Treatment of Male and Female Infertility

Indeterminate GlobeNewswire
Rakovina Therapeutics Announces Upcoming Webinar with Variational AI
December 10, 2025

Rakovina Therapeutics Announces Upcoming Webinar with Variational AI

Indeterminate GlobeNewswire
DeeVid AI Supercharges Video Creation with Leading Models and New AI Video Agent Workflow
December 10, 2025

DeeVid AI Supercharges Video Creation with Leading Models and New AI Video Agent Workflow

Indeterminate GlobeNewswire
Bioxodes lève 5,5 millions d'euros dans le cadre d'une extension de la Série A afin de poursuivre la préparation d’un essai pivot pour son candidat-médicament innovant dans le traitement de l'AVC
December 10, 2025

Bioxodes lève 5,5 millions d'euros dans le cadre d'une extension de la Série A afin de poursuivre la préparation d’un essai pivot pour son candidat-médicament innovant dans le traitement de l'AVC

Indeterminate GlobeNewswire
LightSolver’s Dani Gluck to Speak on Laser-Based Computing at Quantum Algorithms and Optimization in Athens
December 10, 2025

LightSolver’s Dani Gluck to Speak on Laser-Based Computing at Quantum Algorithms and Optimization in Athens

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions